EDBI Pte Ltd
EDBI Pte Ltd is a company.
Financial History
Leadership Team
Key people at EDBI Pte Ltd.
EDBI Pte Ltd is a company.
Key people at EDBI Pte Ltd.
Key people at EDBI Pte Ltd.
EDBI Pte Ltd is the corporate investment arm of Singapore's Economic Development Board (EDB), established in 1991 as a global investor headquartered in Singapore. It focuses on high-growth technology sectors such as information and communication technology (ICT), biotech, fintech, AI, and advanced manufacturing, with a mission to empower tech innovators and catalyze sustainable growth through strategic investments.[1][2][3][4] EDBI's investment philosophy emphasizes resilience, sustainability, and long-term value creation, supporting startups and scale-ups via capital, networks, and operating expertise; it has influenced Singapore's startup ecosystem by backing transformative companies like Hummingbird Bioscience (biotech), Endowus (fintech), Circles (telco innovation), and Doctor Anywhere (telemedicine), while participating in high-profile rounds such as AI chipmaker D-Matrix's $275M raise at a $2B valuation.[1]
Founded in 1991 under the Singapore Economic Development Board, EDBI emerged as a government-backed vehicle to drive economic growth through technology investments, evolving from a focus on ICT to broader high-growth areas like AI, biotech, and climate tech amid global tech shifts.[1][2][3][4] Key figures include Managing Partner Chia Li Yeung, who oversees investments, value creation, and communications, alongside professionals like Investment Analysts Elvis Chua and Estella Goh, and Investments Professional Gerald Teng.[3] Over three decades, EDBI has adapted its mandate to Southeast Asia's booming tech landscape, partnering with global players like Temasek and expanding into multimodal investments, including recent hubs like Omio's Singapore base.[1]
EDBI rides Southeast Asia's tech surge, fueled by AI, generative tech, and digital infrastructure expansion, positioning Singapore as a hub amid U.S.-China tensions and supply chain shifts.[1][2] Its timing aligns with post-pandemic resilience demands, backing trends like AI inference chips (D-Matrix), telemedicine (Doctor Anywhere), and multimodal travel (Omio), which capitalize on regional growth in fintech, healthtech, and climate solutions.[1] Market forces such as SEA's young demographics, rising VC inflows, and sustainability mandates favor EDBI, amplifying Singapore's influence by drawing international talent and capital while nurturing local champions that scale globally.[2][4]
EDBI is poised to deepen AI, biotech, and sustainable tech bets, potentially leading more $100M+ rounds as SEA's ecosystem matures toward unicorn density rivaling Silicon Valley. Trends like generative AI in telco/logistics and cross-border fintech will shape its path, evolving its role from investor to ecosystem architect via deeper EDB synergies. This builds on its 30+ year legacy of turning Singapore's vision into global tech leadership, sustaining high-growth impact.